ArticleAntimicrobial agents and chemotherapy2021

Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19".

Effat Davoudi-Monfared et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.